⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14197970 | 1.00 | — | — | |
| SCHEMBL1117526 | 0.80 | — | — | |
| SCHEMBL1117502 | 0.77 | — | — | |
| SCHEMBL1006247 | 0.75 | — | — | |
| SCHEMBL22433362 | 0.75 | — | — | |
| SCHEMBL1006882 | 0.75 | — | — | |
| SCHEMBL16953 | 0.75 | — | — | |
| SCHEMBL1117476 | 0.75 | ALDH1A1 (0.43) | — | |
| SCHEMBL18040167 | 0.74 | — | — | |
| SCHEMBL3785497 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004272-A1 | BIOCIDAL COMPOSITION OF 2,6-DIMETHYL-M-DIOXANE-4-OL ACETATE AND METHODS OF USE | JI KATHY J (CN) | 2012-01-05 | — | — | US | claimed |
| EP-2346327-A2 | BIOCIDAL COMPOSITIONS AND METHODS OF USE | Dow Global Technologies LLC (US) | 2011-07-27 | — | — | EP | claimed |
| EP-1751199-B1 | NOVEL PHENOLIC RESINS | ANGUS CHEMICAL (US) | 2010-11-24 | — | — | EP | claimed |
| WO-2010108324-A1 | BIOCIDAL COMPOSITION OF 2,6-DIMETHYL-M-DIOXANE-4-OL ACETATE AND METHODS OF USE | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-09-30 | — | — | WO | claimed |
| WO-2010039923-A2 | BIOCIDAL COMPOSITIONS AND METHODS OF USE | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-04-08 | — | — | WO | claimed |
| US-20100078393-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USE | DOW GLOBAL TECHNOLOGIES LLC | 2010-04-01 | — | — | US | claimed |
| US-7319131-B2 | Phenolic resins | ANGUS CHEMICAL COMPANY (US) | 2008-01-15 | — | — | US | claimed |
| US-5460797-A | Method for fixing tissues and cells for analysis using oxazolidine compounds | STRECK LABORATORIES, INC. (US) | 1995-10-24 | — | — | US | claimed |
| US-4042520-A | EXOTHERMIC REDOX REACTIONS OF HYDROGEN PEROXIDE AND OXAZOLIDINES | IMC CHEMICAL GROUP, INC. (US) | 1977-08-16 | — | — | US | claimed |
| US-10189841-B2 | Purinones as ubiquitin-specific protease 1 inhibitors | FORMA THERAPEUTICS, INC. (US) | 2019-01-29 | — | — | US | disclosed |
| US-20180170944-A1 | USE OF THE FL-ONE HUNDRED EIGHTEEN CORE CHEMICAL STRUCTURE PLATFORM TO GENERATE FL-ONE HUNDRED EIGHTEEN DERIVATIVES FOR TREATMENT OF HUMAN DISEASE | CANGET BIOTEKPHARMA, LLC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20170145012-A1 | PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS | FORMA THERAPEUTICS, INC. | 2017-05-25 | — | — | US | disclosed |
| US-20130137709-A1 | Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith | Gatekeeper Pharmaceuticals, Inc. | 2013-05-30 | — | — | US | disclosed |
| CN-101684078-B | Chemical synthesis method for of 2-amino-butanamide hydrochloride | UNIV ZHEJIANG TECHNOLOGY | 2013-01-16 | — | — | CN | disclosed |
| US-20070027147-A1 | Biarylurea derivatives | MSD K.K. (JP) | 2007-02-01 | — | — | US | disclosed |
| WO-2005108453-A1 | NOVEL PHENOLIC RESINS | ANGUS CHEMICAL COMPANY (US) | 2005-11-17 | — | — | WO | disclosed |
| US-20050054787-A1 | Novel phenolic resins | ANGUS CHEMICAL COMPANY | 2005-03-10 | — | — | US | disclosed |
| US-5460797-A | Method for fixing tissues and cells for analysis using oxazolidine compounds | STRECK LABORATORIES, INC. (US) | 1995-10-24 | — | — | US | disclosed |
| US-4088655-A | ANTIMICROBIAL AGENTS | IMC CHEMICAL GROUP, INC. (US) | 1978-05-09 | — | — | US | disclosed |
| US-4042520-A | EXOTHERMIC REDOX REACTIONS OF HYDROGEN PEROXIDE AND OXAZOLIDINES | IMC CHEMICAL GROUP, INC. (US) | 1977-08-16 | — | — | US | disclosed |